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Abstract
Type 1 diabetes management can be challenging for children and their families. To address psychosocial concerns for parents of
youth with type 1 diabetes, we developed two parent-focused interventions to reduce their diabetes distress and fear of hypoglycemia.
Our team conducted several of these interventions during the early stages of the COVID-19 pandemic and recognized a need to
make timely adjustments to our interventions. In this viewpoint article, we describe our experience conducting these manualized
treatment groups during the pandemic, the range of challenges and concerns specific to COVID-19 that parents expressed, and
how we adjusted our approach to better address parents’ treatment needs.
(JMIR Pediatr Parent 2021;4(2):e25106) doi: 10.2196/25106
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Introduction
The daily self-management of type 1 diabetes (T1D) is complex
and unrelenting. It involves regular glucose monitoring, healthy
eating and carbohydrate assessment, insulin administration via
syringe or continuous subcutaneous insulin infusion, and
physical activity [1]. The goal of modern T1D self-management
is to maintain near-normal glucose levels [1]. However, for
many families of youth with T1D, this goal can be very hard to
achieve [2,3]. There is evidence that many parents of youth with
T1D experience diabetes distress and fear of hypoglycemia,
which may negatively impact their functioning and quality of
life [4-6]. Further, parents who report maladaptive coping
strategies also report decreases in mental and physical health
[7]. In our own work, we found that nearly 60% of parents of
young children with T1D (<6 years) report at least a moderate
level of hypoglycemia fear (FH) [8,9]. In addition, our data and
the results of published studies suggest that between 10%-74%
of parents report diabetes distress (DD) [5,6,10,11]. It is because
of these relatively high prevalence rates for FH and DD among
parents that we developed two novel parent-focused
interventions to increase adaptive coping and reduce their FH
and DD.
Reducing Emotional Distress to
Childhood Hypoglycemia in Parents
Reducing Emotional Distress to Childhood Hypoglycemia in
Parents (REDCHiP) is a manualized and closed group
video-based telehealth intervention [12]. REDCHiP includes
10 sessions (7 group sessions and 3 individual sessions)
delivered over approximately 13 weeks. During REDCHiP,
parents do the following: (1) review T1D education and
problem-solving to increase self-efficacy for the management
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of hypoglycemic events, (2) learn age-appropriate behavioral
parenting strategies to manage child behaviors in the context
of T1D care, and (3) learn cognitive-behavioral therapy (CBT)
strategies to enhance coping with fear and stress related to
hypoglycemia [12]. In our pilot work, parents receiving the
REDCHiP intervention showed significant reductions in their
report of FH (P=.003, d=1.01) and parenting stress (P=.003,
d=0.85), and children with glycated hemoglobin (HbA1c) levels
>7.5% prior to REDCHiP showed a significant reduction in
their HbA1c levels (P=.049, d=0.43) after participating in the
intervention [13]. Based on these promising results, we are now
in the process of conducting a larger randomized clinical trial
to test the efficacy of our REDCHiP intervention versus a
relevant attention control group [14].
Cognitive Adaptations to Reduce
Emotional Stress
To address parents’perceptions of DD, we developed Cognitive
Adaptations to Reduce Emotional Stress (CARES) based on
the theory of stress and coping [15-17]. Like REDCHiP, CARES
is a manualized video-based telehealth intervention that includes
weekly closed group sessions delivered over 8 or 12 weeks,
depending on distress severity. In CARES, we use principles
of CBT to teach parents how to identify unhelpful thoughts,
feelings, and behaviors specific to T1D and how to use both
mindfulness-based strategies (eg, meditation, being in the
moment) and behavioral activation to manage their negative
thoughts and feelings related to T1D. Our preliminary data
suggest a significant reduction in parents’ report of DD as a
result of CARES (d=0.71) [18] and we are currently in the
process of applying for additional grant funding to conduct a
larger randomized clinical trial of this intervention.
Intervention Impacts of COVID-19
In early 2020, the United States, like many other countries,
faced an unprecedented public health event with the rapid spread
of COVID-19. For some families of youth with T1D, COVID-19
may be a new stressor that disrupts routine diabetes care and
negatively impacts family engagement with optimal T1D
self-management behaviors, including healthy eating, physical
activity, and adequate insulin administration. In addition,
exposure to this stressor could increase the risk of youth and/or
their parents developing symptoms of anxiety and depression
or exacerbate symptoms already present. Previous studies
suggest that parent stress and internalizing symptoms may
increase their child’s risk for developing similar symptoms
unless the family engages in more adaptive coping methods
[19]. Further, families may also face increased fear of exposure
to COVID-19, making previously typical activities of daily life
(eg, shopping, work/school, recreation/physical activity) more
difficult to accomplish or seemingly riskier to do. Per the
Centers for Disease Control and Prevention (CDC), diabetes is
a risk factor for severe illness [20], and emerging data from the
T1D Exchange suggest persons with T1D who contract
COVID-19 may be vulnerable to experiencing acute
T1D-specific events including severe hyperglycemia and
diabetes ketoacidosis (DKA) [21]. Thus, it is possible that some
parents of children with T1D may be experiencing added fear
and/or distress because of COVID-19 beyond that of the general
population. During the early spread of COVID-19 in the United
States, our team recognized a need to make some timely
adjustments to our REDCHiP and CARES interventions to help
parents reduce their FH and DD in the context of COVID-19.
In this viewpoint article, we describe our experience conducting
these manualized treatment groups with parents of youth with
T1D during the pandemic, the range of challenges and concerns
specific to COVID-19 that parents brought up in groups, and
how we, in turn, adjusted our approach to better address parents’
experiences and treatment needs.
Participants and Author Viewpoint
All parents who participated in the treatment groups had a child
with a confirmed diagnosis of T1D for at least 6 months who
was following an intensive insulin regimen. We recruited
families of youth between the ages of 1-6 years to the CARES
intervention across sites in the Midwest region of the United
States. We also recruited families of youth between the ages of
5-12 years to the REDCHiP intervention across sites in the
Midwest and Southeast regions of the United States. Each
treatment group contained 3-4 members. As part of the
established procedures for both trials, we video recorded the
telehealth sessions to allow for coding of treatment integrity.
However, these recordings also enabled us to reflect on the
parents’ view and observe the adjustments that group leaders
made in the groups they led. The challenges and adaptations
discussed in this viewpoint were not objectively measured nor
part of a formal qualitative study. Rather, this viewpoint article
is based on experiences of 4 treatment groups (1 CARES and
3 REDCHiP) and our consensus regarding the specific concerns
parents raised in the CARES and REDCHiP treatment groups
during the early months of the COVID-19 pandemic in the
United States and how we observed group leaders adapt the




The participants in our active treatment groups reported several
concerns and challenges when caring for their child with T1D
during the onset of the pandemic. Not surprisingly, a main
concern raised by parents was the perceived risk their child with
T1D may contract COVID-19, which could increase their risk
of negative health outcomes. In the early months of the
COVID-19 pandemic, parents reported increased stress and
anxiety regarding the safety of their child (eg, one parent even
remarked, “[I] see germs everywhere”). Parents commented
that their child with T1D was in a high-risk group, a notion also
frequently highlighted by the media. Moreover, because parents
had learned of a possible association between suboptimal
diabetes management and COVID-19, they felt an increased
pressure to maintain tighter glycemic control for their child.
Some parents also expressed significant concern that their
child’s T1D would be difficult to manage if either the parent or
child became sick. Indeed, families specifically noted heightened
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anxiety about the challenges of managing out-of-range blood
glucose values when their young child with T1D was sick in
the past and this seemed to exacerbate their fears about possible
COVID-19 illness. One family in particular, who had previously
struggled to manage diabetes when their child was sick, reported
significantly changing their lifestyle during cold and flu season
in other years to reduce perceived risk (eg, avoiding sport
activities, libraries). Parents reported that the stress associated
with their child becoming sick further intensified as they started
to seek out more information about the transmission of
COVID-19 (eg, airborne versus surface contact) and when trying
to maintain awareness of current recommendations (ie,
when/where to use a face covering) during a time when new
and sometimes conflicting information was continuously
available.
In addition to anxiety about COVID-19 risk, many families
faced a significant challenge when stay-at-home orders took
effect and schools and local businesses began to shut down,
impacting their typical routines. Maintaining a consistent routine
can be an important component of optimal diabetes management
[1]; it can also be helpful when raising a young child [22,23].
Therefore, adjusting to a substantial change in routine was
challenging for some parents who previously relied on school
schedules for beneficial structure in managing their child’s daily
T1D regimen. Some caregivers reported increased stress due to
taking on increased childcare and diabetes tasks during the day.
Parents also lost access to other childcare options (ie, daycare,
nannies, or extended family/other caregivers), which may have
increased disease management burden as they juggled diabetes
treatment tasks, online teaching, childcare, and their own
work-related responsibilities. Further, many parents noted fewer
opportunities for their child to engage in safe and structured
physical activity and indicated that they were concerned this
would negatively impact their child’s glucose levels. Parents
also noted their own difficulty engaging in behavioral activation
strategies (ie, regular and enjoyable activities to increase mood)
or healthy lifestyle behaviors as a result of stay-at-home orders
and reduced access to activities they would typically choose to
do. Even after stay-at-home restrictions ended for some families,
parents noted a period of suboptimal glycemic control when
they returned to the office after working remotely for several
months. These parents expressed frustration that changing
schedules negatively impacted diabetes management and
indicated heightened worry and guilt about returning to the
office and the potential risk of contracting or exposing their
child to COVID-19.
Another major challenge of COVID-19 discussed during the
treatment groups was each family’s experience of social
isolation. Several parents reported they felt isolated from friends
and unable to use their typical resources to manage daily stress
(ie, gym, church, social gatherings, self-care outside of home).
Similarly, several parents reported they restricted their child’s
play with peers, contributing to their child’s increased sense of
isolation. Parents expressed new worries when they considered
allowing their child to interact with other people. Moreover,
they reported feeling guilty when they did not allow their child
to play with a peer or visit extended family during the
stay-at-home orders. Feelings of isolation were not only specific
to social activities but also included managing T1D. One parent
in particular felt isolated during the stay-at-home order because
her partner did not assist with T1D care and she had come to
rely on her child’s school nurse for help with diabetes
management during the school day. Unfortunately, during the
stay-at-home orders she was unable to access assistance from
the school nurse. Some parents also reported that it was
challenging to attend the treatment group sessions during the
stay-at-home orders and that they felt overwhelmed by all their
responsibilities. In fact, several families who had previously
expressed interest in participating in a group declined to
participate during the stay-at-home orders, citing difficulty in
attending the treatment groups while simultaneously having all
family members at home. Further, we had parents frequently
reschedule their meeting times to accommodate changes in their
daily schedules. Lastly, another untimely challenge that parents
reported was COVID-19–related job loss or furloughs, which
in some cases had a downstream impact on the family’s financial
stability and insurance status. However, even parents who did
not experience job loss reported concerns about their job security
or their ability to find a new job and how that could impact their
family’s insurance status and ability to pay for T1D management
supplies.
Positive Outcomes and Family Resilience
Despite the negative impacts of COVID-19 on many families,
group leaders also noted positive outcomes and family resilience
during this unprecedented time. Some families did not express
specific concerns for their child related to COVID-19 and
adapted to changes in lifestyle and schedules smoothly. Some
parents even noted an improvement in their child’s blood
glucose levels, which they attributed to their increased
monitoring of T1D management tasks during stay-at-home
orders. Families expressed gratitude for the support they
received from the group members and group leaders. Even in
the context of COVID-19–related challenges and concerns,
many families continued to arrive to each session and remained
engaged in group discussions. Several parents reported that their
group participation increased as their schedules became more
flexible as a result of working from home. Lastly, parents
expressed appreciation for the extra family time they
experienced related to stay-at-home orders.
Treatment Adjustments and
Considerations
To address the unique challenges and concerns raised during
the treatment groups, and to continue to reduce parent fear and
distress, group leaders made small adjustments in their approach,
using clinical judgment. One common adjustment was to
incorporate strategies consistent with Acceptance and
Commitment Therapy [24]. In the context of COVID-19, these
strategies seemed particularly appropriate, especially given the
uncertainty and the changes happening outside of participants’
control. For example, when parents talked about their child
feeling isolated from peers and unhappy, group leaders
individually determined that problem-solving and information
seeking might not provide parents the desired relief from
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negative feelings. Instead, the group leaders tried acceptance
and commitment strategies aimed at helping the parents to accept
that their child could feel isolation from time to time during the
stay-at-home order and to commit to moving forward in life
based on their values. Similarly, specific to T1D care, when
parents reported difficulty in managing their child’s diabetes,
the group leaders aimed to increase parents’ acceptance and
tolerance of temporary child blood glucose fluctuations during
periods of transition, while still helping parents commit to
actions aligned with an eventual return to more stable T1D
management. Group leaders also employed these strategies to
help parents process any feelings of guilt related to returning
to the office or when discussing a family’s decision to reduce
their level of isolation (eg, playing with neighborhood peers,
cousins). Group leaders discussed pros and cons of accepting
different imperfect outcomes, such as increased feelings of
isolation or increased risk of exposure, and helped families
consider how they could commit to the course that best fit their
perceived needs (eg, reduced risk of infection, children’s social
development).
In addition to adjusting some therapeutic strategies, group
leaders commonly spent more time and emphasis on
problem-solving than initially planned, especially when aiming
to increase parents’ use of behavioral activation strategies and
helping them to identify available activities that were considered
safe during COVID-19. For example, group leaders reported
spending a lot of time on problem-solving strategies to help
parents socialize and spend time with friends or extended family
in a manner that felt comfortable and was within the scope of
public health recommendations (eg, outdoor socially distanced
walks with a friend/neighbor). The group leaders encouraged
parents to embrace creative ways to achieve personal self-care
(eg, spa night at home) and to integrate positive coping
techniques despite the unique challenges of COVID-19 (eg,
weekly video conversations with friends/family, virtual church
service, outdoor and socially distant activities). Lastly, a novel
behavior that many parents engaged in during groups was to
seek advice from the group leader or other parents on whether
their child should return to school. In these situations, the group
leaders helped parents use risk-assessment strategies that were
not initially part of either manualized treatment. Fortunately,
problem-solving and soliciting parent examples to work through
during the group sessions were already typical activities for
both the REDCHiP and CARES interventions, which helped
the group leaders make these adjustments more seamlessly.
Future Directions
After addressing unique COVID-19–related challenges within
each treatment group, our team hypothesized that there could
be an increased risk for some parents to remain inappropriately
hypervigilant about their child’s health after COVID-19
subsides, and that this could be an important area of ongoing
concern for families. Interestingly, group leaders noted that
some parents with higher levels of pre-existing anxiety reported
a decrease in anxiety related to the stay-at-home orders. In many
cases, these parents reported that they thought they could easily
meet their child’s needs without interacting with others and that
having their child home would be more conducive to monitoring
their child’s health and T1D management nearly continuously.
Although this may seem like a short-term improvement in
anxiety (and potentially T1D management), this avoidant-based
coping strategy could lead to longer term risks and challenges,
especially if families rely too heavily on this strategy and
continue to resist leaving their home for work, school, or
social/recreation activities. In the time of COVID-19, it might
not have been recommended that these families expose
themselves to situations that increased their anxiety (eg, going
for a socially distanced walk with friends), but nonetheless,
group leaders continued to challenge families to expose
themselves to situations and try new activities just outside their
comfort zone (but still in line with CDC and medical team
recommendations) in an effort to reduce the likelihood that
families might adopt a lifestyle of avoiding anxiety-producing
situations.
Lastly, our a priori decision to run treatment groups via a
videoconferencing platform enabled group leaders to continue
with scheduled sessions as stay-at-home orders took place,
without a break in either treatment group. The use of telehealth
services has recently become a large focus, in both medical and
mental health service delivery, and this shift in service delivery
may continue well into the future now that many families have
experience with a telehealth platform. Although some services
will return to in-person delivery as social distancing
requirements are reduced, we would encourage providers to
advocate that telehealth services remain an option for families.
There are several benefits to continuing to provide telehealth
services after COVID-19 subsides, such as increasing access to
services for families living in rural areas, with limited
transportation options, or with limited time available for such
services. Although the available literature specific to the
transition to telehealth services during the pandemic is limited,
emerging research suggests telemedicine may be an effective
approach for some families. For example, Garg and colleagues
[25] presented a case example of using telemedicine to provide
ongoing diabetes education to a pediatric patient with new-onset
T1D. Their conclusion was that a telemedicine approach could
be well-suited to families who use T1D devices (ie, insulin
pump, continuous glucose monitor) where it is feasible to collect
data remotely. Thus, the opportunities videoconferencing and
telehealth affords us may continue to improve our ability to
provide effective services to youth and families and reduce
disparities in health care access both now and into the future.
Conclusions
During the global COVID-19 pandemic, families of children
with T1D faced new challenges, including widespread anxiety
and activity restrictions to avoid COVID-19 exposure, while
concurrently demonstrating marked resilience. Our research
team was fortunate to work closely with families during this
uncertain time through the REDCHiP and CARES group-based
telehealth interventions. With some adjustments (ie, increased
scheduling flexibility, greater focus on acceptance strategies,
and additional time spent on problem-solving), we saw that
parents continued to attend our treatment groups and to show
individual success in managing negative affect related to T1D.
As the COVID-19 pandemic evolves, we anticipate new
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concerns requiring further intervention or adjustment, such as
difficulties returning to activities previously avoided to reduce
COVID-19 risk, fluctuations in blood glucose following changes
in routines, and/or increased burnout as many parents continue
to shoulder responsibilities for childcare, school, T1D
management, and their own work with no immediate end in
sight. Further, formal qualitative studies are needed to
intentionally assess the concerns we present in this viewpoint
as the information provided was not the result of planned data
collection. Future researchers and clinicians may consider
formally assessing these concerns among patients and families
to understand the extent to which these concerns impact daily
functioning. We hope for the continued (and even more
widespread) use of telehealth to deliver interventions to reduce
anxiety and distress for families and children with T1D.
Although research on the impacts of COVID-19 on families
with children with T1D may be underway, it will also be
important to exchange more anecdotal perspectives during this
period of rapid change.
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